Axim Biotechnologies Inc (AXIM): New U.S. Patent Allowance Granted to AXI...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: None

Thursday, 10/05/2017 10:47:38 AM

Thursday, October 05, 2017 10:47:38 AM

New U.S. Patent Allowance Granted to AXIM® Biotechnologies, Inc. for Cannabinoid Ophthalmic Solutions for Glaucoma and Conjunctivitis Treatment

https://globenewswire.com/news-release/2017/10/05/1141427/0/en/New-U-S-Patent-Allowance-Granted-to-AXIM-Biotechnologies-Inc-for-Cannabinoid-Ophthalmic-Solutions-for-Glaucoma-and-Conjunctivitis-Treatment.html

Boom! indeed!

Know What You Own. My posts should not be construed as investment advice.

Keep Last Read

Replies (1) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 04:59:09 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:29:50 PM
Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/21/2023 03:07:21 PM
Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 08/31/2023 08:10:23 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 05:35:50 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:11:37 PM

InvestorsHub NewsWire

FEATURED Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • Apr 22, 2024 8:49 AM

Only $200 per official company press release!